Breadcrumb Home Studies Studies Search Filter Research Area AllComplications & ComorbiditiesCureTreatmentTuberculosis Study Status AllClosed to AccrualClosed to Follow UpConcludedEnrollingIn DevelopmentParticipants Off Study and Primary Analysis CompletedPending Sort Study Number AscStudy Number Desc Submit Search Showing 10 studies. IMPAACT 2026: Pharmacokinetic Properties of Antiretroviral and Anti-Tuberculosis Drugs During Pregnancy and Postpartum DAIDS Number 38609 Research Area Therapeutics Study Status Enrolling P1083: Kaletra/Aluvia PK study DAIDS Number 10787 Research Area Treatment Study Status Concluded P1079: PHARMACOLOGY OF ARTEMISININ-BASED ANTIMALARIAL THERAPY DAIDS Number 10765 Research Area Other Study Status Concluded P1071: CCR5 Vicriviroc (SCH-417690) DAIDS Number 10634 Research Area N/A Study Status Concluded P1069: GPO-VIR Z30 DAIDS Number 10620 Research Area Other Study Status Concluded P1058A: Pharmacokinetics of New Classes of Antiretroviral Drug Combinations DAIDS Number 10809 Research Area Other Study Status Concluded P1056: GPO-VIR PK Study DAIDS Number 10139 Research Area Other Study Status Concluded P1032: Prevention of Development of Nevirapine-Resistance Mutations in Postpartum Women DAIDS Number 10137 Research Area Other Study Status Concluded P1026S: PK in Pregnancy DAIDS Number Therapeutics Research Area Treatment Study Status Closed to Follow Up P1025: Perinatal Core Protocol DAIDS Number 10039 Research Area Prevention Study Status Concluded
IMPAACT 2026: Pharmacokinetic Properties of Antiretroviral and Anti-Tuberculosis Drugs During Pregnancy and Postpartum DAIDS Number 38609 Research Area Therapeutics Study Status Enrolling
P1079: PHARMACOLOGY OF ARTEMISININ-BASED ANTIMALARIAL THERAPY DAIDS Number 10765 Research Area Other Study Status Concluded
P1058A: Pharmacokinetics of New Classes of Antiretroviral Drug Combinations DAIDS Number 10809 Research Area Other Study Status Concluded
P1032: Prevention of Development of Nevirapine-Resistance Mutations in Postpartum Women DAIDS Number 10137 Research Area Other Study Status Concluded
P1026S: PK in Pregnancy DAIDS Number Therapeutics Research Area Treatment Study Status Closed to Follow Up
